share_log

Craig-Hallum Maintains Buy on BioLife Solns, Lowers Price Target to $23

Benzinga ·  Aug 10, 2023 15:43

Craig-Hallum analyst Matt Hewitt maintains BioLife Solns (NASDAQ:BLFS) with a Buy and lowers the price target from $29 to $23.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment